+ |
CyclinD/CDK4 | down-regulates quantity by destabilization
phosphorylation
|
MEF2D |
0.268 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276888 |
Ser110 |
GEDSLEQsPLLEDKY |
Mus musculus |
NIH-3T3 Cell |
pmid |
sentence |
25733682 |
MEF2C and MEF2D interact with the E3 ligase F-box protein SKP2, which mediates their subsequent degradation through the ubiquitin-proteasome system. The cyclin-dependent kinase 4 (CDK4)/cyclin D1 complex phosphorylates MEF2D on serine residues 98 and 110, and phosphorylation of these residues is an important determinant for SKP2 binding. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276887 |
Ser98 |
KGFNGCDsPEPDGED |
Mus musculus |
NIH-3T3 Cell |
pmid |
sentence |
25733682 |
MEF2C and MEF2D interact with the E3 ligase F-box protein SKP2, which mediates their subsequent degradation through the ubiquitin-proteasome system. The cyclin-dependent kinase 4 (CDK4)/cyclin D1 complex phosphorylates MEF2D on serine residues 98 and 110, and phosphorylation of these residues is an important determinant for SKP2 binding. |
|
Publications: |
2 |
Organism: |
Mus Musculus |
Pathways: | IGF and Myogenesis |
+ |
CyclinD/CDK4 | up-regulates activity
phosphorylation
|
UNG |
0.283 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276087 |
Ser12 |
KTLYSFFsPSPARKR |
Homo sapiens |
HeLa Cell |
pmid |
sentence |
18079698 |
We investigated the ability of four active CDK/cyclin pairs to phosphorylate UNG2 in vitro.When UNG2 was subjected to in vitro phosphorylation by either of these sets of CDK/cyclins, multiple phosphorylated forms of UNG2 were observed (Figure 5B). Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases.Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases (Figure 5B, upper panels) in agreement with the accumulation of this phosphorylation in G2 (Figure 3B). In addition, (unspecific) phosphorylation by all kinases was observed at S12 and S14. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276085 |
Ser14 |
LYSFFSPsPARKRHA |
Homo sapiens |
HeLa Cell |
pmid |
sentence |
18079698 |
We investigated the ability of four active CDK/cyclin pairs to phosphorylate UNG2 in vitro.When UNG2 was subjected to in vitro phosphorylation by either of these sets of CDK/cyclins, multiple phosphorylated forms of UNG2 were observed (Figure 5B). Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases.Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases (Figure 5B, upper panels) in agreement with the accumulation of this phosphorylation in G2 (Figure 3B). In addition, (unspecific) phosphorylation by all kinases was observed at S12 and S14. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276084 |
Ser23 |
ARKRHAPsPEPAVQG |
Homo sapiens |
HeLa Cell |
pmid |
sentence |
18079698 |
We investigated the ability of four active CDK/cyclin pairs to phosphorylate UNG2 in vitro.When UNG2 was subjected to in vitro phosphorylation by either of these sets of CDK/cyclins, multiple phosphorylated forms of UNG2 were observed (Figure 5B). Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases.Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases (Figure 5B, upper panels) in agreement with the accumulation of this phosphorylation in G2 (Figure 3B). In addition, (unspecific) phosphorylation by all kinases was observed at S12 and S14. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276086 |
Thr60 |
AGQEEPGtPPSSPLS |
Homo sapiens |
HeLa Cell |
pmid |
sentence |
18079698 |
We investigated the ability of four active CDK/cyclin pairs to phosphorylate UNG2 in vitro.When UNG2 was subjected to in vitro phosphorylation by either of these sets of CDK/cyclins, multiple phosphorylated forms of UNG2 were observed (Figure 5B). Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases.Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases (Figure 5B, upper panels) in agreement with the accumulation of this phosphorylation in G2 (Figure 3B). In addition, (unspecific) phosphorylation by all kinases was observed at S12 and S14. |
|
Publications: |
4 |
Organism: |
Homo Sapiens |
+ |
CyclinD/CDK4 | up-regulates activity
phosphorylation
|
TSC2 |
0.481 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-274099 |
Ser1217 |
MSLENPLsPFSSDIN |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
32294430 |
We show here that CyclinD-Cdk4/6 activates mTORC1 by binding and phosphorylating TSC2 on Ser1217 and Ser1452. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-274100 |
Ser1452 |
LPSSSPRsPSGLRPR |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
32294430 |
We show here that CyclinD-Cdk4/6 activates mTORC1 by binding and phosphorylating TSC2 on Ser1217 and Ser1452. |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
+ |
CyclinD/CDK4 | down-regulates
phosphorylation
|
RASSF1 |
0.489 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216976 |
Ser207 |
TSVRRRTsFYLPKDA |
Homo sapiens |
|
pmid |
sentence |
18071316 |
This skp2-dependent destruction of rassf1a requires phosphorylation of the latter on serine-203 by cyclin d-cyclin-dependent kinase 4. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinD/CDK4 | down-regulates
phosphorylation
|
RUNX3 |
0.528 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216980 |
Ser356 |
SSSGGDRsPTRMLAS |
Homo sapiens |
|
pmid |
sentence |
19351720 |
Our findings demonstrate that the cell cycle proteins cyclin d1 and cdk4 induce runx2 and runx3 phosphorylation, ubiquitylation and proteasomal degradation. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinD/CDK4 | up-regulates activity
phosphorylation
|
KAT2A |
0.402 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-275496 |
Ser372 |
EEIYGANsPIWESGF |
|
|
pmid |
sentence |
24870244 |
Activated cyclin D1-Cdk4 kinase phosphorylates and activates GCN5|GCN5 T272A/S372A (AA) phosphorylation by cyclin D1-CDK4 kinase is diminished compared to GCN5 wild-type (WT) |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-275497 |
Thr272 |
LNYWKLEtPAQFRQR |
|
|
pmid |
sentence |
24870244 |
Activated cyclin D1-Cdk4 kinase phosphorylates and activates GCN5|GCN5 T272A/S372A (AA) phosphorylation by cyclin D1-CDK4 kinase is diminished compared to GCN5 wild-type (WT) |
|
Publications: |
2 |
+ |
CyclinD/CDK4 | down-regulates quantity by destabilization
phosphorylation
|
CDC25A |
0.638 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-277340 |
Ser40 |
ASAAGGLsPVTNLTV |
Homo sapiens |
A-431 Cell |
pmid |
sentence |
28192398 |
We demonstrate that CyclinD-CDK4/CDK6 complexes mediate the phosphorylation of CDC25A on Ser40 during G1 and that these complexes directly phosphorylate this residue in vitro. Importantly, we also find that CyclinD1-CDK4 decreases CDC25A stability in a ßTrCP-dependent manner and that Ser40 and Ser88 phosphorylations contribute to this regulation. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-277342 |
Ser88 |
DSGFCLDsPGPLDSK |
Homo sapiens |
A-431 Cell |
pmid |
sentence |
28192398 |
We demonstrate that CyclinD-CDK4/CDK6 complexes mediate the phosphorylation of CDC25A on Ser40 during G1 and that these complexes directly phosphorylate this residue in vitro. Importantly, we also find that CyclinD1-CDK4 decreases CDC25A stability in a ßTrCP-dependent manner and that Ser40 and Ser88 phosphorylations contribute to this regulation. |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
Pathways: | Cell cycle: G1/S phase transition, Cell cycle: G2/M phase transition |
+ |
CyclinD/CDK4 | up-regulates activity
phosphorylation
|
UBTF |
0.345 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250754 |
Ser484 |
ERGKLPEsPKRAEEI |
Mus musculus |
NIH-3T3 Cell |
pmid |
sentence |
10202152 |
We have identified Ser484 as a direct target for cyclin-dependent kinase 4 (cdk4)-cyclin D1- and cdk2-cyclin E-directed phosphorylation. Mutation of Ser484 impairs rDNA transcription in vivo and in vitro. |
|
Publications: |
1 |
Organism: |
Mus Musculus |
+ |
CyclinD/CDK4 | down-regulates
phosphorylation
|
BRCA1 |
0.579 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216984 |
Ser632 |
LVVSRNLsPPNCTEL |
Homo sapiens |
Breast Cancer Cell |
pmid |
sentence |
17334399 |
In particular, we have identified ser 632 of brca1 as a cyclin d1/cdk4 phosphorylation site in vitro. Using chromatin immunoprecipitation assays, we observed that the inhibition of cyclin d1/cdk4 activity resulted in increased brca1 dna binding at particular promoters in vivo. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Cell cycle: G2/M phase transition |
+ |
CyclinD/CDK4 | down-regulates activity
phosphorylation
|
RB1 |
0.858 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216988 |
Ser780 |
STRPPTLsPIPHIPR |
Homo sapiens |
Breast Cancer Cell |
pmid |
sentence |
23336272 |
Cyclin d1 is known to activate cdk4, which then phosphorylates the rb protein, leading to cell cycle progression. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250759 |
Ser788 |
PIPHIPRsPYKFPSS |
in vitro |
|
pmid |
sentence |
9139732 |
In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216992 |
Ser795 |
SPYKFPSsPLRIPGG |
Homo sapiens |
Breast Cancer Cell |
pmid |
sentence |
23336272 |
Cyclin d1 is known to activate cdk4, which then phosphorylates the rb protein, leading to cell cycle progression. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250760 |
Thr356 |
DSFETQRtPRKSNLD |
in vitro |
|
pmid |
sentence |
9139732 |
In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250762 |
Thr5 |
tPRKTAAT |
in vitro |
|
pmid |
sentence |
9139732 |
In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216957 |
Thr826 |
LPTPTKMtPRSRILV |
Homo sapiens |
|
pmid |
sentence |
9139732 |
We demonstrate that phosphorylation by either cdk2-cyclin a, which phosphorylates t821, or cdk4-cyclin d1, which phosphorylates threonine 826, can disable prb for subsequent binding of an lxcxe protein. |
|
Publications: |
6 |
Organism: |
Homo Sapiens, In Vitro |
Pathways: | Cell cycle: G1/S phase transition, Cell cycle: G2/M phase transition, Luminal Breast Cancer, Malignant Melanoma, IGF and Myogenesis, Pancreatic ductal adenocarcinoma (PDA), Rhabdomyosarcoma |
+ |
CyclinD/CDK4 | down-regulates
binding
|
MEF2C |
0.292 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216963 |
|
|
Homo sapiens |
|
pmid |
sentence |
21902831 |
In contrast to cdk2, cyclin d/cdk4 blocks myod activity through an as yet unclear mechanism that may involve direct binding. Cyclin d/cdk4 can also block the activity of myogenin and all mef2 isoforms. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | IGF and Myogenesis |
+ |
CyclinD/CDK4 | down-regulates
binding
|
MEF2D |
0.268 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216966 |
|
|
Homo sapiens |
|
pmid |
sentence |
21902831 |
In contrast to cdk2, cyclin d/cdk4 blocks myod activity through an as yet unclear mechanism that may involve direct binding. Cyclin d/cdk4 can also block the activity of myogenin and all mef2 isoforms. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | IGF and Myogenesis |
+ |
CyclinD/CDK4 | down-regulates
binding
|
MYOD1 |
0.444 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216969 |
|
|
Homo sapiens |
|
pmid |
sentence |
21902831 |
In contrast to cdk2, cyclin d/cdk4 blocks myod activity through an as yet unclear mechanism that may involve direct binding. Cyclin d/cdk4 can also block the activity of myogenin and all mef2 isoforms. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | IGF and Myogenesis, Rhabdomyosarcoma |
+ |
CyclinD/CDK4 | down-regulates
binding
|
MYOG |
0.346 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216972 |
|
|
Homo sapiens |
|
pmid |
sentence |
21902831 |
In contrast to cdk2, cyclin d/cdk4 blocks myod activity through an as yet unclear mechanism that may involve direct binding. Cyclin d/cdk4 can also block the activity of myogenin and all mef2 isoforms. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | IGF and Myogenesis, Rhabdomyosarcoma |
+ |
CyclinD/CDK4 | up-regulates
|
G0/G1_transition |
0.7 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273193 |
|
|
|
|
pmid |
sentence |
12640120 |
Transition through this point requires cdk6/4-cyclin D, since inhibition with TAT-p16INK4A during the first 3 to 5 h prevents cell cycle entry and maintains both naive and memory T cells in G0. |
|
Publications: |
1 |
+ |
CDKN2A | down-regulates activity
binding
|
CyclinD/CDK4 |
0.822 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-245459 |
|
|
Homo sapiens |
|
pmid |
sentence |
11154267 |
Overexpression of p16INK4a in cells with functional pRb results in inhibition of both Cdk4- and Cdk6-associated kinase activity and pRb phosphorylation, with subsequent cell cycle arrest (46, 50). In addition, inhibition of D cyclin-Cdk4 complex formation by p16INK4a prevents sequestration of p21Cip1 and p27Kip1 by these complexes in early G1, leading to suppression of cyclin E-Cdk2 activity |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-217514 |
|
|
Homo sapiens |
|
pmid |
sentence |
8891723 |
The first group, including p16ink4a, p15ink4b,p18ink4cand p19ink4d, is specific for the g1 cdks,cdk4and cdk6, inhibiting the kinase activity of cyclin d/cdk4-cdk6 complexes on prb. |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
Pathways: | Cell cycle: G1/S phase transition, Cell cycle: G2/M phase transition, Luminal Breast Cancer, Malignant Melanoma, Pancreatic ductal adenocarcinoma (PDA), Rhabdomyosarcoma |
+ |
CDK4 | form complex
binding
|
CyclinD/CDK4 |
0.964 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-32301 |
|
|
Homo sapiens |
|
pmid |
sentence |
7736585 |
D-type cyclins (cyclin d1, d2, or d3) and their associated cyclin-dependent kinases (cdk4, cdk6) connect signals from cytokines to the cell cycle machinery, and they propel cells through the g1 restriction point and into the s phase when activated by cyclin d1, cdk4 is able to phosphorylate prb, |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Pancreatic ductal adenocarcinoma (PDA) |
+ |
GSK3B | down-regulates quantity by destabilization
phosphorylation
|
CyclinD/CDK4 |
0.606 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-245432 |
|
|
Homo sapiens |
|
pmid |
sentence |
23552696 |
Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1 |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Cell cycle: G1/S phase transition, Cell cycle: G2/M phase transition, IGF and Myogenesis |
+ |
CCND1 | form complex
binding
|
CyclinD/CDK4 |
0.964 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-32298 |
|
|
Homo sapiens |
|
pmid |
sentence |
7736585 |
D-type cyclins (cyclin d1, d2, or d3) and their associated cyclin-dependent kinases (cdk4, cdk6) connect signals from cytokines to the cell cycle machinery, and they propel cells through the g1 restriction point and into the s phase when activated by cyclin d1, cdk4 is able to phosphorylate prb, |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CDC25A | up-regulates activity
dephosphorylation
|
CyclinD/CDK4 |
0.638 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-245456 |
|
|
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
23429262 |
We show that the miRNA-induced silencing of CDC25A increases the tyrosine phosphorylation status of CDK4/6 cyclin-dependent kinases which, in turn, abolishes CDK4/6 capacity to associate with D-type cyclins. This prevents CDK4/6 kinases activation, impairs downstream events such as cyclin E stimulation and sequesters cells in early G1. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Cell cycle: G1/S phase transition, Cell cycle: G2/M phase transition |
+ |
AQP5 | up-regulates activity
binding
|
CyclinD/CDK4 |
0.249 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-272089 |
|
|
|
|
pmid |
sentence |
18583321 |
We performed immunoprecipitation and western blotting analysis in transfected cell lines using CDK4 and cyclin D1 antibodies. As expected, cells transfected with AQP5 WT showed an increase of the CDK4/cyclin D1 complex, whereas cells transfected with vector did not|hAQP5 Increases Phosphorylation of Retinoblastoma Protein through Cyclin D1/CDK4 Complex |
|
Publications: |
1 |
+ |
CyclinD/CDK4 | down-regulates
binding
|
MEF2A |
0.271 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216960 |
|
|
Homo sapiens |
|
pmid |
sentence |
21902831 |
In contrast to cdk2, cyclin d/cdk4 blocks myod activity through an as yet unclear mechanism that may involve direct binding. Cyclin d/cdk4 can also block the activity of myogenin and all mef2 isoforms. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | IGF and Myogenesis |